Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biofactor GmbH is a specialized German pharmaceutical company that focuses on the production and global distribution of high-purity biological active pharmaceutical ingredients (APIs). Established in 1987, the company is a leading supplier of essential enzymes and proteins, most notably Aprotinin, which is used to reduce blood loss during complex surgical procedures. Their extensive product portfolio also includes digestive enzymes such as Pancreatin, Trypsin, and Chymotrypsin, as well as critical coagulation factors and anticoagulants like Heparin and Thrombin. Biofactor serves a diverse international clientele across the pharmaceutical, diagnostic, and cosmetic industries from its GMP-compliant facilities in Illertissen. The company is recognized for its expertise in the extraction and purification of biological substances from natural sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biofactor.